Acknowledgement to Referees

Publicado no Mol Diagn Ther (2020)

The Path Forward for COVID-19 Diagnostics

Por Usherwood, Thomas, Zhang, Lei, Tripathi, Anubhav
Publicado no Mol Diagn Ther (2020)

The Potential Role of Smartphone-Based Microfluidic Systems for Rapid Detection of COVID-19 Using Saliva Specimen

Por Farshidfar, Nima, Hamedani, Shahram
Publicado no Mol Diagn Ther (2020)

The importance of standardization on analyzing circulating RNA

Por Lee, Inyoul, Baxter, David, Lee, Min Young, Scherler, Kelsey, Wang, Kai
Publicado no Mol Diagn Ther (2017)

Attenuation of Inherited and Acquired Retinal Degeneration Progression with Gene-based Techniques

Por Cho, Galaxy Y., Bolo, Kyle, Park, Karen Sophia, Sengillo, Jesse D., Tsang, Stephen H.
Publicado no Mol Diagn Ther (2019)

First Responder to Genomic Information: A Guide for Primary Care Providers

Por Haga, Susanne B.
Publicado no Mol Diagn Ther (2019)

Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential

Por Galletti, Giuseppe, Portella, Luigi, Tagawa, Scott T., Kirby, Brian J., Giannakakou, Paraskevi, Nanus, David M.
Publicado em 2014

Commercial Multiplex Technologies for the Microbiological Diagnosis of Sepsis

Por Lebovitz, Evan E., Burbelo, Peter D.
Publicado em 2013

Cell-free eccDNAs: a new type of nucleic acid component for liquid biopsy?

Por Zhu, Jing, Chen, Siyu, Zhang, Fan, Wang, Liang
Publicado no Mol Diagn Ther (2018)

Only Connect: Personal Genomics and the Future of American Medicine

Por Angrist, Misha
Publicado em 2010

TP53 Testing and Li-Fraumeni Syndrome: Current Status of Clinical Applications and Future Directions

Por Sorrell, April D., Espenschied, Carin R., Culver, Julie O., Weitzel, Jeffrey N.
Publicado em 2013

Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests

Por Goodison, Steve, Rosser, Charles J., Urquidi, Virginia
Publicado em 2013

Biomarker Testing for Ovarian Cancer: Clinical Utility of Multiplex Assays

Por Nolen, Brian M., Lokshin, Anna E.
Publicado em 2013

HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies

Por English, Diana P., Roque, Dana M., Santin, Alessandro D.
Publicado em 2013

Comprehensive Profiling of EGFR/HER Receptors for Personalized Treatment of Gynecologic Cancers

Por Reyes, Henry D., Thiel, Kristina W., Carlson, Matthew J., Meng, Xiangbing, Yang, Shujie, Stephan, Jean- Marie, Leslie, Kimberly K.
Publicado em 2014

Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients

Por Fesler, Andrew, Jiang, Jingting, Zhai, Haiyan, Ju, Jingfang
Publicado em 2014

Deleted in liver cancer-1 (DLC-1): An emerging metastasis suppressor gene

Por Popescu, Nicholas C., Goodison, Steve
Publicado em 2014

PHARMACOGENETICS AND PHARMACOGENOMICS OF TARGETED THERAPEUTICS IN CHRONIC MYELOID LEUKEMIA

Por Nath, Aritro, Wang, Jacqueline, Huang, R. Stephanie
Publicado no Mol Diagn Ther (2017)

Exploiting Circulating miRNAs as Biomarkers in Psychiatric Disorders

Por Roy, Bhaskar, Yoshino, Yuta, Allen, Lauren, Prall, Kevin, Schell, Grant, Dwivedi, Yogesh
Publicado no Mol Diagn Ther (2020)

Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients

Por Chalkias, Athanasios, Mouzarou, Angeliki, Samara, Evangelia, Xanthos, Theodoros, Ischaki, Eleni, Pantazopoulos, Ioannis
Publicado no Mol Diagn Ther (2020)